Hypera Stock

Hypera EBITDA per Share

The EBITDA per Share of Hypera (HYPE3.SA) as of Sep 5, 2026 is 3.02 BRL. In the previous year, EBITDA per Share was 3.27 BRL — a change of -7.46% (lower).

EBITDA per Share

3.02BRL

YoY

-7.46%

Last updated:

EBITDA per Share of Hypera is 2026 3.02 BRL. EBITDA per Share of Hypera was 2025 3.27 BRL. It decreases by -7.46% lower compared to the previous year.

The Hypera EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
2.09 BRL
Jan 1, 2019
1.76 BRL
Jan 1, 2020
2.32 BRL
Jan 1, 2021
3.32 BRL
Jan 1, 2022
4.22 BRL
Jan 1, 2023
3.86 BRL
Jan 1, 2024
3.27 BRL
Jan 1, 2025
3.02 BRL
The Hypera EBITDA per Share history
YEAREBITDA per ShareYoY
3.02BRL-7.46%
3.27BRL-15.42%
3.86BRL-8.36%
4.22BRL+27.04%
3.32BRL+43.20%
2.32BRL+31.96%
1.76BRL-15.79%
2.09BRL+10.28%
1.89BRL+5.70%
1.79BRL+20.83%
1.48BRL+0.70%
1.47BRL
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

EBITDA per Share of Hypera is 3.02 BRL in 2026.

EBITDA per Share of Hypera changed from 3.27 BRL to 3.02 BRL, representing a -7.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Hypera since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

Income Statement — Hypera

All Key Metrics — Hypera